Sublethal necroptosis signaling promotes inflammation and liver cancer
Mihael Vucur,Ahmed Ghallab,Anne T Schneider,Arlind Adili,Mingbo Cheng,Mirco Castoldi,Michael T Singer,Veronika Büttner,Leonie S Keysberg,Lena Küsgens,Marlene Kohlhepp,Boris Görg,Suchira Gallage,Jose Efren Barragan Avila,Kristian Unger,Claus Kordes,Anne-Laure Leblond,Wiebke Albrecht,Sven H Loosen,Carolin Lohr,Markus S Jördens,Anne Babler,Sikander Hayat,David Schumacher,Maria T Koenen,Olivier Govaere,Mark V Boekschoten,Simone Jörs,Carlos Villacorta-Martin,Vincenzo Mazzaferro,Josep M Llovet,Ralf Weiskirchen,Jakob N Kather,Patrick Starlinger,Michael Trauner,Mark Luedde,Lara R Heij,Ulf P Neumann,Verena Keitel,Johannes G Bode,Rebekka K Schneider,Frank Tacke,Bodo Levkau,Twan Lammers,Georg Fluegen,Theodore Alexandrov,Amy L Collins,Glyn Nelson,Fiona Oakley,Derek A Mann,Christoph Roderburg,Thomas Longerich,Achim Weber,Augusto Villanueva,Andre L Samson,James M Murphy,Rafael Kramann,Fabian Geisler,Ivan G Costa,Jan G Hengstler,Mathias Heikenwalder,Tom Luedde
DOI: https://doi.org/10.1016/j.immuni.2023.05.017
IF: 32.4
2023-07-11
Immunity
Abstract:It is currently not well known how necroptosis and necroptosis responses manifest in vivo. Here, we uncovered a molecular switch facilitating reprogramming between two alternative modes of necroptosis signaling in hepatocytes, fundamentally affecting immune responses and hepatocarcinogenesis. Concomitant necrosome and NF-κB activation in hepatocytes, which physiologically express low concentrations of receptor-interacting kinase 3 (RIPK3), did not lead to immediate cell death but forced them into a prolonged "sublethal" state with leaky membranes, functioning as secretory cells that released specific chemokines including CCL20 and MCP-1. This triggered hepatic cell proliferation as well as activation of procarcinogenic monocyte-derived macrophage cell clusters, contributing to hepatocarcinogenesis. In contrast, necrosome activation in hepatocytes with inactive NF-κB-signaling caused an accelerated execution of necroptosis, limiting alarmin release, and thereby preventing inflammation and hepatocarcinogenesis. Consistently, intratumoral NF-κB-necroptosis signatures were associated with poor prognosis in human hepatocarcinogenesis. Therefore, pharmacological reprogramming between these distinct forms of necroptosis may represent a promising strategy against hepatocellular carcinoma.